tetano
Editor, Senior Moderator
Discov Immunol
. 2023 Aug 19;2(1):kyad014.
doi: 10.1093/discim/kyad014. eCollection 2023. Triphasic production of IFN γ by innate and adaptive lymphocytes following influenza A virus infection
George E Finney[SUP] 1 [/SUP], Kerrie E Hargrave[SUP] 1 [/SUP], Marieke Pingen[SUP] 1 [/SUP], Thomas Purnell[SUP] 1 [/SUP], David Todd[SUP] 1 [/SUP], Freya MacDonald[SUP] 1 [/SUP], Julie C Worrell[SUP] 1 [/SUP], Megan K L MacLeod[SUP] 1 [/SUP]
Affiliations
Interferon gamma (IFNγ) is a potent antiviral cytokine that can be produced by many innate and adaptive immune cells during infection. Currently, our understanding of which cells produce IFNγ and where they are located at different stages of an infection is limited. We have used reporter mice to investigate in vivo expression of Ifnγ mRNA in the lung and secondary lymphoid organs during and following influenza A virus (IAV) infection. We observed a triphasic production of Ifnγ expression. Unconventional T cells and innate lymphoid cells, particularly NK cells, were the dominant producers of early Ifnγ, while CD4 and CD8 T cells were the main producers by day 10 post-infection. Following viral clearance, some memory CD4 and CD8 T cells continued to express Ifnγ in the lungs and draining lymph node. Interestingly, Ifnγ production by lymph node natural killer (NK), NKT, and innate lymphoid type 1 cells also continued to be above naïve levels, suggesting memory-like phenotypes for these cells. Analysis of the localization of Ifnγ+ memory CD4 and CD8 T cells demonstrated that cytokine+ T cells were located near airways and in the lung parenchyma. Following a second IAV challenge, lung IAV-specific CD8 T cells rapidly increased their expression of Ifnγ while CD4 T cells in the draining lymph node increased their Ifnγ response. Together, these data suggest that Ifnγ production fluctuates based on cellular source and location, both of which could impact subsequent immune responses.
Keywords: immune memory; influenza A virus; interferon-gamma; lung; trained immunity.
. 2023 Aug 19;2(1):kyad014.
doi: 10.1093/discim/kyad014. eCollection 2023. Triphasic production of IFN γ by innate and adaptive lymphocytes following influenza A virus infection
George E Finney[SUP] 1 [/SUP], Kerrie E Hargrave[SUP] 1 [/SUP], Marieke Pingen[SUP] 1 [/SUP], Thomas Purnell[SUP] 1 [/SUP], David Todd[SUP] 1 [/SUP], Freya MacDonald[SUP] 1 [/SUP], Julie C Worrell[SUP] 1 [/SUP], Megan K L MacLeod[SUP] 1 [/SUP]
Affiliations
- PMID: 37842651
- PMCID: PMC10568397
- DOI: 10.1093/discim/kyad014
Interferon gamma (IFNγ) is a potent antiviral cytokine that can be produced by many innate and adaptive immune cells during infection. Currently, our understanding of which cells produce IFNγ and where they are located at different stages of an infection is limited. We have used reporter mice to investigate in vivo expression of Ifnγ mRNA in the lung and secondary lymphoid organs during and following influenza A virus (IAV) infection. We observed a triphasic production of Ifnγ expression. Unconventional T cells and innate lymphoid cells, particularly NK cells, were the dominant producers of early Ifnγ, while CD4 and CD8 T cells were the main producers by day 10 post-infection. Following viral clearance, some memory CD4 and CD8 T cells continued to express Ifnγ in the lungs and draining lymph node. Interestingly, Ifnγ production by lymph node natural killer (NK), NKT, and innate lymphoid type 1 cells also continued to be above naïve levels, suggesting memory-like phenotypes for these cells. Analysis of the localization of Ifnγ+ memory CD4 and CD8 T cells demonstrated that cytokine+ T cells were located near airways and in the lung parenchyma. Following a second IAV challenge, lung IAV-specific CD8 T cells rapidly increased their expression of Ifnγ while CD4 T cells in the draining lymph node increased their Ifnγ response. Together, these data suggest that Ifnγ production fluctuates based on cellular source and location, both of which could impact subsequent immune responses.
Keywords: immune memory; influenza A virus; interferon-gamma; lung; trained immunity.